Up to 10 million Americans live with OCD, yet only one in six receive a correct diagnosis. As a result, 95% of people in the ...

In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for obsessive-compulsive disorder than cannabinoids.

Howie Mandel didn't get diagnosed with OCD until his 40s, but doesn't remember a time without it. He talks about NOCD, AI ...

Women are using heart medication propranolol for anxiety relief at weddings and dates, but experts warn about safety risks as ...

With a late-stage miss reported for its prospective social anxiety disorder (SAD) treatment fasedienol, Vistagen’s chances at ...

A new clinical trial underway in the Lowcountry is drawing attention for its unconventional — and potentially groundbreaking ...

Investing.com -- Vistagen (NASDAQ:VTGN) stock plunged 78.8% Wednesday after the company announced its Phase 3 study of fasedienol for social anxiety disorder failed to meet its primary endpoint.

A randomized trial showed that a smartphone-delivered digital CBT intervention improved generalized anxiety disorder symptoms in adults. The self-paced program uses evidence-based CBT techniques such ...

Fasedienol is a first-in-class pherine nasal spray that is designed to modulate the olfactory-limbic amygdala fear and anxiety neurocircuits.

Through the five-year study, researchers are testing approaches that can make high-quality mental health treatment easier for ...

I've always approached new medications with caution, concerned about potential side effects. That hesitation is why it took me several weeks to finally try Pulmozyme for the first time.

Liking, wanting, and craving cannabis come from genetics, stress vulnerability, and the desire to "treat" depression, anxiety ...